Efficacy Study of Mirtazapine to Treat Interferon-related Depression During Antiviral Therapy for Hepatitis C
Status:
Terminated
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the anti-depressive efficacy of mirtazapine in
depression induced by peginterferon alpha-2a and ribavirin treatment in Korean patients with
chronic hepatitis C.